|
Personalized diagnosis and treatment of hyperinsulinemic hypoglycaemia caused by beta-cell pathology |
|
1st April 2014 |
|
4 years |
|
€ 6 million |
|
Stichting Katholieke Universiteit, Radboud University Nijmegen Medical School – Prof. Martin Gotthardt |